[1] 王丽.何首乌炮制后化学成分及药理作用分析.中国现代药物应用,2020,14:229-231. [2] 杨德华,曾义岚,陈竹,等.93例急性药物性肝损伤的临床分析.中国肝脏病杂志,2013,5:28-30. [3] Jung KA, Min HJ, Yoo SS,et al. Drug-induced liver injury: twenty five cases of acute hepatitis following ingestion of polygonum multiflorum thunb. Gut Liver,2011,5:493-499. [4] Wang Y, Wang L, Saxena R,et al. Clinicopathological features of He Shou Wu-induced liver injury: this ancient anti-aging therapy is not liver-friendly. Liver Int,2019,39:389-400. [5] 朱云,李永纲,王葽等.595例中药导致肝损伤临床特征分析.中国中西医结合杂志,2016,36:44-48. [6] 常乙玲,李娜.何首乌及其制剂致药物性肝损伤系统性回顾研究.中国药业,2020,29:81-86. [7] 涂灿,葛斐林,郭玉明,等.何首乌相关肝损伤临床特征及用药合理性分析.中国药物警戒,2019,16:270-276. [8] 李春雨,李晓菲,涂灿,等.基于内毒素模型的何首乌特异质肝损伤评价.药学学报,2015,50:28-33. [9] 宋海波,沈传勇.中药安全用药与风险防控的探索及实践——以何首乌为例的安全风险管理.中国食品药品监管,2020:12-18. [10] 马致洁,李晓菲,吕旸,等.基于肝细胞毒价检测的何首乌炮制工艺比较研究.中国中药杂志,2015,40:2325-2329. [11] 杨磊,刘梦娇,陈文明,等.2种炮制方法对何首乌中6种成分变化的影响.中成药,2019,41:119-123. [12] 郜丹,李晓菲,尹萍,等. 基于炮制减毒思想的何首乌肝毒性物质基础初步研究. 中草药, 2017, 48: 2044-2050. [13] 林艳,李亚梅,吴萍,等.何首乌肝毒性的物质基础、毒性机制与防控策略.世界科学技术-中医药现代化,2019,21:1862-1868. [14] 李婷婷,李瑞红,刘振兴,等.基于类器官3D培养的何首乌易感物质肝毒性评价.药学学报,2017,52:1048-1054. [15] Li C, Niu M, Bai Z,et al. Screening for main components associated with the idiosyncratic hepatotoxicity of a tonic herb, Polygonum multiflorum. Front Med,2017,11:253-265. [16] 张乐,柏兆方,李春雨,等. 制首乌中顺式二苯乙烯苷转化量与特异质肝损伤的相关性研究. 药学学报, 2017, 52 (7): 1041-1047. [17] Zhang L, LIU X, Tu C, et al. Components synergy between stilbenes and emodin derivatives contributes to hepatotoxicity induced by Polygonummultiflorum. Xenobiotica, 2020, 50(5): 515-525. [18] 肖小河,郭玉明,王伽伯,等.中草药相关肝损伤的科学评价与防控——以何首乌为例.中西医结合肝病杂志,2021,31:193-196. [19] Metushi IG, Hayes MA, Uetrecht J. Treatment of PD-1(-/-) mice with amodiaquine and anti-CTLA4 leads to liver injury similar to idiosyncratic liver injury in patients. Hepatology,2015,61:1332-1342. [20] Syrbu SI, Cohen MB. An enhanced antigen-retrieval protocol for immunohistochemical staining of formalin-fixed, paraffin-embedded tissues. Methods Mol Biol,2011,717:101-110. [21] Sgro C, Clinard F, Ouazir K,et al. Incidence of drug-induced hepatic injuries: a French population-based study. Hepatology,2002,36:451-455. [22] Björnsson ES, Bergmann OM, Björnsson HK,et al. Incidence, presentation, and outcomes in patients with drug-induced liver injury in the general population of Iceland. Gastroenterology,2013,144:1419-1425, 1425.e1-3; quiz e19-20. [23] Shen T, Liu Y, Shang J,et al. Incidence and etiology of drug-induced liver injury in mainland China. Gastroenterology,2019,156:2230-2241.e11. [24] 王艳,王昱,王岚,等.中草药与西药致药物性肝损伤的临床特征及其预后的对比研究.肝脏,2021,26:364-369. [25] 胡锡琴,禚君,李娅琳,等.何首乌中二苯乙烯苷对大鼠肝酶及蛋白的影响.辽宁中医杂志,2011,38:988-990. [26] 李娜,宋捷,李晓菲,等.药物代谢酶抑制剂对反式二苯乙烯苷所致肝损伤易感性的影响.药学学报,2017,52:1063-1068. [27] Zeng C, Xiao JH, Chang MJ,et al. Beneficial effects of THSG on acetic acid-induced experimental colitis: involvement of upregulation of PPAR-γ and inhibition of the NF-κB inflammatory pathway. Molecules,2011,16:8552-8568. [28] 李正刚,曲涵婷,李本淳,等.何首乌黑豆酒炙的炮制工艺研究.亚太传统医药,2021,17:37-40. [29] 蒲俊安,张思敏,刘梦娇,等.何首乌九蒸九晒炮制工艺的优化研究中国药房,2020,31:2713-2719. [30] Li C, Rao T, Chen X,et al. HLA-B*35:01 allele is a potential biomarker for predicting polygonum multiflorum-induced liver injury in humans. Hepatology, 2019,70:346-357. [31] 庞晶瑶,柏兆方,牛明,等.基于“有故无殒”的何首乌对正常和肝损伤大鼠的毒性与保护作用对比研究.药学学报,2015,50:973-979. |